Researchers Propose Framework for Digital Pathology Adoption
A new study outlines a lifecycle-oriented approach to help laboratories navigate costs, regulatory compliance, and artificial intelligence readiness.
A new study outlines a lifecycle-oriented approach to help laboratories navigate costs, regulatory compliance, and artificial intelligence readiness.
The panel integrates biomarker testing and digital tools to support fibrosis risk assessment and liver cancer surveillance.
Lucent Diagnostics and Tempus AI have partnered to integrate blood-based Alzheimer’s biomarker testing into clinical workflows, aiming to expand access and improve detection accuracy for neurologists.
SYNERGEN Health has launched IGNITE, an AI-driven revenue cycle management platform for laboratories, designed to address denied claims and delayed reimbursements.
Stellaris is designed to significantly improve how scientists are able to capture three-dimensional images of living cells and tissues.
The collaboration pairs AI pathology algorithms with global laboratory infrastructure to help biopharma teams speed up evidence generation and diagnostic launch timelines.